The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.81 for the 2020 fiscal year.
Its low valuation, with P/E ratio at 11.72 and 10.18 for the ongoing fiscal year and 2021 respectively, makes the stock pretty attractive with regard to earnings multiples.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The group shows a rather high level of debt in proportion to its EBITDA.
The group usually releases earnings worse than estimated.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
The underlying tendency is negative on the weekly chart below the resistance at 12.1 EUR
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
